Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Terri L. Guinipero
Biography
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Terri L. Guinipero
Biography
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Terri L. Guinipero
Contact Information
- Call us at:
- (614) 722-3550
- Fax us at:
- (614) 722-3369
- PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Terri L. Guinipero
Biography
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Biography
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Biography
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Dr. Guinipero serves as the Hematology/Oncology Medical Director at Nationwide Children’s and is an associate clinical professor at The Ohio State University. She is the Co-Director of the Leukemia/Lymphoma team. Her clinical interests are acute myelogenous leukemia and acute lymphoblastic leukemia. Dr. Guinipero received her medical degree from Universidad Autonoma De Guadalajara, Mexico. She completed her pediatric residency at University of Illinois in Chicago and her pediatric hematology/oncology fellowship at Children’s Hospital of Pittsburgh of UPMC.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Locations
Main Campus of Nationwide Children’s Hospital
Languages Spoken
English Spanish
Main Campus of Nationwide Children’s Hospital
English
Spanish
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
- Hematology/Oncology & BMT
- Physician Team
- Hematology, Oncology and BMT Fellowship
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Hematology & Oncology
Research
Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
Research
Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
Research
Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
View More Publications
- Guinipero T, Kahwash SB. Morphologic findings often provide guidance when immunophenotypic data overlap: a case of AML with cup-shaped nuclei. Blood. 2022 Sep 22; 140: 1448.
- Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 Jun 21; e29812.
- Verdoni AM, Zilla ML, Bullock G, Guinipero TL, Meade J, Yatsenko SA. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Am J Med Genet A. 2022 Jun 9;
- Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson B, Samis J, Aimone P, Allepuz A, Titorenko K, Sosothikul D. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Adv. 2021 Jul 27; 5: 2925-2934.
- Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021 May; 38: 659-663.
- Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol. 2020 Sep 21;
- Liu H, Guinipero TL, Schieffer KM, Carter C, Colace S, Leonard JR, Orr BA, Kahwash SB, Brennan PJ, Fitch JR, Kelly B, Magrini VJ, White P, Wilson RK, Mardis ER, Cottrell CE, Boué DR. De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation. Haematologica. 2020 Apr; 105: e194-e197.
- Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O’Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 Feb 14;
- Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Aimone P, Allepuz A, Quenet S, Hourcade-Potelleret F, Hertle S, Sosothikul D. Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Blood. 2019 Sep 11;
- Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer. 2019 Sep 5; e27978.
- Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122: 126-129.
- Coven SL, Bibart M, Frost R, Gallagher T, Guinipero T, Valasek AE, Olshefski R. A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia. Pediatr Qual Saf. 2019 Jul-Aug; 4: e198.
Education
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
Education
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
Education
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
Date of Appointment at Nationwide Children’s Hospital: 09/23/2011
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Children’s Hospital of Pittsburgh of UPMC
Date Completed: 08/30/2010
Residency
University of Illinois Medical Center at Chicago
Date Completed: 06/30/2007
Medical School
Universidad Autonoma De Guadalajara
Date Completed: 06/30/2003
- Pediatric Hematology Oncology
- Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-3550
- Fax us at:
- (614) 722-3369
- Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
